The effect of constipation on rectal dosimetry following prostate brachytherapy

Merrick, 1997, Prostatic conformal brachytherapy, Radiat. Oncol. Invest., 5, 305, 10.1002/(SICI)1520-6823(1997)5:6<305::AID-ROI7>3.0.CO;2-1

Merrick, 1998, The influence of timing on the dosimetric analysis of transperineal ultrasound guided prostatic conformal brachytherapy, Radiat. Oncol. Invest., 6, 182, 10.1002/(SICI)1520-6823(1998)6:4<182::AID-ROI6>3.0.CO;2-U

Merrick, 1999, Potential role of various dosimetric quality indicators in prostate brachytherapy, Int. J. Radiat. Oncol. Biol. Phys., 44, 717, 10.1016/S0360-3016(99)00067-X

Wallner, 1995, Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy, Int. J. Radiat. Oncol. Biol. Phys., 32, 465, 10.1016/0360-3016(94)00599-G

Willins, 1997, CT based dosimetry for transperineal I-125 prostate brachytherapy, Int. J. Radiat. Oncol. Biol. Phys., 39, 347, 10.1016/S0360-3016(97)00322-2

Prestidge, 1998, Timing of computed tomography based post-implant assessment following permanent transperineal prostate brachytherapy, Int. J. Radiat. Oncol. Biol. Phys., 40, 1111, 10.1016/S0360-3016(97)00947-4

Stock, 1998, A dose response study for I-125 prostate implants, Int. J. Radiat. Oncol. Biol. Phys., 41, 101, 10.1016/S0360-3016(98)00006-6

Waterman, 1998, Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry, Int. J. Radiat. Oncol. Biol. Phys., 41, 1069, 10.1016/S0360-3016(98)00152-7

Merrick, 1999, Rectal dosimetric analysis following prostate brachytherapy, Int. J. Radiat. Oncol. Biol. Phys., 43, 1021, 10.1016/S0360-3016(98)00486-6

Johanson, 1998, Geographic distribution of constipation in the United States, Am. J. Gastroenterol., 93, 188, 10.1111/j.1572-0241.1998.00188.x

Camilleri, 1994, Clinical management of intractable constipation, Ann. Intern. Med., 121, 520, 10.7326/0003-4819-121-7-199410010-00008

Mishalany, 1989, Seven years’ experience with idiopathic unremitting chronic constipation, J. Pediatric. Surg., 24, 360, 10.1016/S0022-3468(89)80269-6

Prather, 1998, and treatment of constipation and fecal impaction in adults, Mayo Clin. Proc., 73, 881, 10.4065/73.9.881

Blasko, 1993, Brachytherapy and organ preservation in the management of carcinoma of the prostate, Semin. Radiat. Oncol., 3, 240, 10.1016/S1053-4296(05)80121-3

Stock, 1996, Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate cancer, Cancer, 77, 2386, 10.1002/(SICI)1097-0142(19960601)77:11<2386::AID-CNCR30>3.0.CO;2-R

Wallner, 1994, Short term freedom from disease progression after I-125 prostate implantation, Int. J. Radiat. Oncol. Biol. Phys., 30, 405, 10.1016/0360-3016(94)90021-3

Wallner, 1996, Tumor control and morbidity following transperineal I-125 implantation for stage T1/T2 prostatic carcinoma, J. Clin. Oncol., 14, 449, 10.1200/JCO.1996.14.2.449

Waterman, 1999, Effect of post-implant edema on the rectal dose in prostate brachytherapy, Int. J. Radiat. Oncol. Biol. Phys., 45, 571, 10.1016/S0360-3016(99)00230-8